Do surgeons follow the rules for bleeding control? new study investigates

NCT ID NCT07699016

Recruiting now Knowledge-focused Sponsor: University of Milan Source: ClinicalTrials.gov ↗

First seen Jul 13, 2026 · Last updated Jul 14, 2026 · Updated 1 time

Summary

This study looks at how surgeons at one hospital in Milan choose hemostatic agents—medicines that help stop bleeding during heart and blood vessel surgery. Researchers will survey surgeons about their knowledge and compare it to a review of hospital records to see if actual use matches best-practice guidelines. The goal is to find gaps and opportunities to improve care and reduce waste.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If the study finds gaps between guidelines and real-world use, it could lead to better training and standardized practices, potentially improving patient safety and reducing costs.
What could go wrong: This is a small, single-center observational study with only 15 participants, so findings may not apply to other hospitals or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIAC SURGERY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARDIAC SURGERY CARDIOVASCULAR SURGERY HEMOSTASIS PERIOPERATIVE BLEEDING VASCULAR SURGERY

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

IRCCS Galeazzi Sant'Ambrogio Hospital
RECRUITING

Milan, MI, 20157, Italy

Contact

Contact

Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.